Risk factors for Alzheimer's disease.
Richard A Armstrong
|
8 |
2019 |
8
2019
|
Molecular mechanisms of neuropathological changes in Alzheimer's disease: a review.
O. Šerý,
J. Povová,
I. Míšek,
Lukáš Pešák,
V. Janout
|
7 |
2013 |
7
2013
|
The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer's disease.
R. Armstrong
|
7 |
2009 |
7
2009
|
Quantitative analysis of activated microglia, ramified and damage of processes in the frontal and temporal lobes of chronic schizophrenics.
T. Wierzba-Bobrowicz,
E. Lewandowska,
W. Lechowicz,
T. Stępień,
E. Pasennik
|
6 |
2005 |
6
2005
|
What causes alzheimer's disease?
Richard A. Armstrong
|
6 |
2013 |
6
2013
|
The role of excitotoxicity in neurodegeneration.
E. Salińska,
W. Danysz,
J. Łazarewicz
|
6 |
2006 |
6
2006
|
Differentiation between brain tumor recurrence and radiation injury using perfusion, diffusion-weighted imaging and MR spectroscopy.
B. Bobek-Billewicz,
G. Stasik-Pres,
H. Majchrzak,
Lukasz Zarudzki
|
6 |
2010 |
6
2010
|
A critical analysis of the 'amyloid cascade hypothesis'.
R. Armstrong
|
6 |
2014 |
6
2014
|
The neuroprotective function of vascular endothelial growth factor (VEGF).
K. Góra-Kupilas,
J. Jośko
|
6 |
2005 |
6
2005
|
Neurodegeneration and oxidative stress: prion disease results from loss of antioxidant defence.
David R. Brown
|
6 |
2006 |
6
2006
|
Established and emerging variants of glioblastoma multiforme: review of morphological and molecular features.
M. Karsy,
M. Gelbman,
Paarth Shah,
Odessa Balumbu,
F. Moy,
E. Arslan
|
6 |
2012 |
6
2012
|
Neuronal death in the rat hippocampus in experimental diabetes and cerebral ischaemia treated with antioxidants.
P. Piotrowski,
K. Wierzbicka,
M. Śmiałek
|
6 |
2001 |
6
2001
|
Qualitative and quantitative analysis of locus coeruleus neurons in Parkinson's disease.
E. Bertrand,
W. Lechowicz,
Szpak Gm,
J. Dymecki
|
6 |
1997 |
6
1997
|
